EGFR附体和PEG功能化蛋白质纳米颗粒:维持向和巨细胞逃避
Seonhye Jang1, Heejin Jun2, Soomin Eom2
1Department of Pharmaceutical Engineering, INJE University, Gimhae 50834, Republic of Korea.
International journal of biological macromolecules
|March 21, 2025
概括
PEGylated蛋白质纳米颗粒逃避免疫清除并保持细胞向. 这增强了它们的体内半衰期,并允许它们与目标细胞进行特定的结合,克服了免疫系统的识别能力.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 免疫学 免疫学 免疫学
背景情况:
- 生物系统中的纳米粒子迅速获得血清蛋白质,导致opsonization和免疫清除.
- 这种免疫识别限制了纳米粒子的治疗潜力和体内循环时间.
研究的目的:
- 开发隐形蛋白质纳米颗粒,增强体内循环.
- 将特定的细胞向能力赋予PEGylated纳米颗粒.
主要方法:
- 蛋白质纳米颗粒与聚乙烯糖醇 (PEG) 的功能化,以创建隐形特性.
- 纳入表皮生长因子受体抗体片段 (EGFRAfb) 进行向传递.
- 在体外和体内对纳米颗粒与巨细胞和细胞相互作用的评估.
主要成果:
- 基化显著降低了巨细胞的opsonization和随后的细胞化.
- 与EGFRAfb功能化的PEGylated纳米颗粒保留了与细胞的特定结合.
- 与未经修改的纳米粒子相比,修改后的纳米粒子在体内半衰期增加.
结论:
- PEGylated蛋白质纳米颗粒表现出隐形性质,减少免疫清除并增加半衰期.
- 纳米粒子保持有针对性的传递能力,使特定的细胞结合.
- 这种双重功能为先进的纳米医学应用提供了一个有前途的平台.
更多相关视频
09:36Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
Published on: February 5, 2019
8.6K
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.6K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
